Login / Signup
Joanna Baginska
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 4
Top Topics
Inflammatory Response
Open Label
Placebo Controlled
Phase Ii Study
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Candace L Haddox
,
Michael J Nathenson
,
Emanuele Mazzola
,
Jia-Ren Lin
,
Joanna Baginska
,
Allison N Nau
,
Jason L Weirather
,
Edwin Choy
,
Adrian Mariño-Enriquez
,
Jeffrey A Morgan
,
Gregory M Cote
,
Priscilla A Merriam
,
Andrew J Wagner
,
Peter Karl Sorger
,
Sandro Santagata
,
Suzanne George
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft Tissue Sarcomas: Clinical Outcomes and Biological Correlates.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Candace L Haddox
,
Michael J Nathenson
,
Emanuele Mazzola
,
Jia-Ren Lin
,
Joanna Baginska
,
Allison N Nau
,
Jason L Weirather
,
Edwin Choy
,
Adrian Mariño-Enriquez
,
Jeffrey A Morgan
,
Gregory M Cote
,
Priscilla A Merriam
,
Andrew J Wagner
,
Peter Karl Sorger
,
Sandro Santagata
,
Suzanne George
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (7) (2024)
Candace L Haddox
,
Michael J Nathenson
,
Emanuele Mazzola
,
Jia-Ren Lin
,
Joanna Baginska
,
Allison N Nau
,
Jason L Weirather
,
Edwin Choy
,
Adrian Mariño-Enriquez
,
Jeffrey A Morgan
,
Gregory M Cote
,
Priscilla A Merriam
,
Andrew J Wagner
,
Peter Karl Sorger
,
Sandro Santagata
,
Suzanne George
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft Tissue Sarcomas: Clinical Outcomes and Biological Correlates.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)
Candace L Haddox
,
Michael J Nathenson
,
Emanuele Mazzola
,
Jia-Ren Lin
,
Joanna Baginska
,
Allison N Nau
,
Jason L Weirather
,
Edwin Choy
,
Adrian Mariño-Enriquez
,
Jeffrey A Morgan
,
Gregory M Cote
,
Priscilla A Merriam
,
Andrew J Wagner
,
Peter Karl Sorger
,
Sandro Santagata
,
Suzanne George
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (7) (2024)